Loading organizations...
Bader Sultan & Brothers Co. W.L.L. distributes diversified healthcare solutions, providing systems, consumables, supplies, and implants. The company supplies a broad range of diagnostic, pharmaceutical, agricultural, veterinary, and medical disposable products. It focuses on importing cutting-edge items from renowned global manufacturers, ensuring high-quality standards and advanced technology integration.
Established in 1960, Bader Sultan & Brothers originated in Kuwait as a dedicated healthcare solutions provider. Its foundational presence in the region’s medical supply chain developed over six decades, demonstrating a long-standing commitment. This history reflects robust operational capabilities and a deep understanding of market requirements.
The company serves public and private healthcare markets by distributing essential medical and diagnostic equipment and supplies. Bader Sultan & Brothers aims to leverage future technologies for present populations. Its vision centers on continuously enhancing healthcare accessibility and quality through its comprehensive product portfolio and established distribution network.
Bader Sultan & Bros. has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Debt / Series D in Obalon Therapeutics in January 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 15, 2015 | Obalon Therapeutics | $30.0M Debt / Series D | — | Axon Ventures, Domain Associates, Interwest Partners, Mirae Asset Venture Investment, Neoplux, Okapi Venture Capital, Scott Foote, Striker Asia Opportunities Fund |